Justice Mehta Questions Role of Pricing Authority in Drug Price Surge

The bench pointed out that roughly 82 % of medicines in the market are not covered by the 2013 Drug (Price Control) Order, which directly controls prices of about 1,000 drugs. With over 60,000 brands sold, only a handful are subject to the cap. Justice Mehta asked whether the lack of transparency at the retailer level truly benefits patients, especially in emergencies when families cannot spend time comparing prices.